Kazia Therapeutics Limited (NASDAQ:KZIA) announced a private placement of approximately $50 million in shares and prefunded warrants, at a purchase price per share equivalent to$5 per ADS. Each ADS represents 500 ordinary shares.The PIPE is structured as a straightforward equity investment with no standard warrant coverage.Also Read: Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock JumpsThe net proceeds are expected to be approximately $46.5 million, and the compan ...